Global Bone Grafts Substitutes Market to Soar in the Near Future Owing to Growing Consumer Adoption

Bone grafts are implantable materials, which promote bone healing, bone formation, and osseous reconstruction due to their osteoconductive, osteogenic, and osteoinductive properties. They're employed in sports, trauma, plastic, facial, and spinal procedures, among other things. Furthermore, they can be employed to fill holes in the lack of bones or to aid in the provision of structural support. Bone grafting is a surgical treatment that replaces a missing or damaged bone with a substance (bone transplant) from the patient's own body, a corpse, animals, or another person. It is used in wound healing, difficult fracture treatment, and other areas.

The growth of the global bone grafts and substitutes market is driven by factors such as rise in incidence of musculoskeletal disorders, development of biocompatible synthetic bone grafts, technological advancements in medical field leading to a shift from autograft to allograft, and increase in demand for dental bone grafts. However, higher costs of surgeries and ethical issues related to bone grafting procedures are anticipated to limit the bone grafts and substitutes market growth. Conversely, increase in focus of key players toward R&D activities in bone grafts & their substitutes and upsurge in demand for orthopedic procedures among geriatric population are expected to provide lucrative opportunities for the market players in the future.

The overall impact of the COVID-19 pandemic is expected to be relatively negative for medical device businesses in the bone grafts and substitutes market. Companies are suffering as a result of the lockdown, which has caused interruptions in supply chain activity around the world. Furthermore, significant industry participants are experiencing challenges with the availability of human resources for manufacturing bone grafts and substitutes at production sites. Furthermore, end users such as hospitals and clinics reported a decrease in patient visits as a result of the global lockdown restrictions. However, the situation is expected to improve as governments around the world begin to reduce regulations for resuming corporate operations. Moreover, the demand for bone grafts & substitutes is likely to increase post recommencing the elective surgeries and procedures in the near future.